Your browser doesn't support javascript.
loading
Bortezomib Is More Effective to Side Population of RPMI8226 Myeloma Cells than Classical Anti-myeloma Agents.
Kim, Kyoung Ha; Cheong, Hee-Jeong; Lee, Min Young; Lee, Namsu; Lee, Kyu-Taek; Park, Seong Kyu; Won, Jong-Ho.
Afiliação
  • Kim KH; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
  • Cheong HJ; Institute for Clinical Molecular Biology Research, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
  • Lee MY; Institute for Clinical Molecular Biology Research, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
  • Lee N; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
  • Lee KT; Institute for Clinical Molecular Biology Research, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
  • Park SK; Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
  • Won JH; Institute for Clinical Molecular Biology Research, Soonchunhyang University College of Medicine, Soonchunhyang University Hospital, Seoul, Republic of Korea.
Anticancer Res ; 39(1): 127-133, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30591449

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bortezomib / Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bortezomib / Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP / Mieloma Múltiplo / Proteínas de Neoplasias Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2019 Tipo de documento: Article